The National Institutes of Health (NIH) announced June 1 that it has started a clinical trial of adults fully vaccinated against COVID-19 receiving a different booster shot approximately three to four months later.
The study will determine the safety and immunogenicity of mixed booster regimens against the CCP virus and emerging variants.
